Frontlight ResearchEarly access
Primary biliary cholangitis trials in South Korea
2 of 3 trials · From ClinicalTrials.gov, checked 17 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleSeladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis
- Where
- Busan, Daegu, Gwangju, Seongnam, Seoul
- Age
- 18 years and over
- People
- 402 worldwide
- Run by
- Gilead Sciences
See details and how to joinNCT06051617 · EU 2024-516525-31-01 - Phase 3Taking peopleA Long-Term Study of Elafibranor in Adult Participants With Primary Biliary Cholangitis
- Where
- Bucheon-si, Busan, Daegu, Daejeon, Goyang-si, Gyeonggi-do, Incheon, Junggu, Seongnam-si, Seoul, Uijeongbu-si
- Age
- 18 years and over
- People
- 276 worldwide
- Run by
- Ipsen
See details and how to joinNCT06016842 · EU 2023-505251-43-00